Introduction
1q21.1 duplication syndrome is a rare aberration of chromosome 1. Chromosome region 1q21.1 contains extensive and complex low-copy repeats. Copy number variants (CNVs) in this region are associated with developmental delay, neuropsychiatric abnormalities, dysmorphic features and a variety of congenital malformations (1, 2) . The characteristics of 1q21.1 deletion [Online Mendelian Inheritance in Man (OMIM) no. 612474] include developmental delay, microcephaly, facial anomalies, cataract and congenital heart defect (CHD). Various anatomic types of CHD have been found in 1q21.1 deletion syndromic patients (3) , including left-sided obstructions as well as conotruncal and septal defects (4) (5) (6) . On the other hand, 1q21.1 duplication (OMIM no. 612475) usually leads to mental impairment, autism, macrocephaly and dysmorphic features (1) . In addition, a 1q21.1 deletion, as well as 1q21.1 duplication, have been found in patients with apparently non-syndromic CHD. An association between Tetralogy of Fallot (TOF) and 1q21.1 duplication or variants in GJA5 gene mapping in 1q21.1 were documented recently (7, 8) .
Latest developments of single nucleotide polymorphism (SNP) array allow genome-wide screening at a resolution (<5 Mb in size) that is undetectable by traditional cytogenetic methods and have facilitated the discovery of a number of novel microdeletion and microduplication syndromes (9) . As part of a larger study on the identification of pathogenic copy number variations in children with CHD (10-12), a high-resolution Illumina SNP array was performed on children with CHD and their parents. The present study provided a detailed report on a Chinese female patient (age, four years and eight months) with developmental delay, neuropsychiatric abnormalities and CHD.
Materials and methods
Ethical approval and patient consent. The Review Board of the Second Xiangya Hospital of the Central South University approved the present study (Changsha, China). Written informed consent was obtained from the parents of the patient for publication of the present study and any accompanying images.
Clinical presentation. In 2011, a female patient (age, four years and eight months) from Central-South China was seen at the Second Xiangya Hospital of Central South University for a heart murmur. The parents of the patient were unrelated and no family history of inherited diseases was present. At birth, the patient presented with lip cyanosis, clubbing and heart defects (tetralogy of fallot, patent duct artery and patent foramen ovale). At the last examination (at the age of four years and eight months), the patient had a height of 75 cm and a weight of 10 kg. A moderate mental impairment and a decreased ability were observed, and her intelligence quotient was 65 compared to 80 at two years of age. The patient did not present with any distinct facial abnormalities (Fig. 1) . The monozygotic twin sister of the patient, however, was physically and psychologically normal.
Cytogenetic analysis. Chromosome analysis was performed by conventional G-banding techniques (550-band resolution) using the peripheral blood samples of the patient, the twin sister and the parents. A sample of 2 ml peripheral blood was collected. All samples were subjected to lymphocyte culture according to a standard cytogenetic protocol. 
SNP array analysis.

Results
The chromosome analysis of the patient revealed a normal female karyotype, described as 46,XX. The twin sister and parents also had a normal karyotype. STR-PCR analysis confirmed that the patient and her sister are identical twins (Table I) . Clinical examination of the patient showed a combination of phenotypes with CHD, developmental delay, mental impairment, neuropsychiatric abnormalities, raising concerns about a chromosomal abnormality of microdeletion/microduplication. To explore the exact genomic lesion of this patient, the SNP array system (Human660w-Quad Chip, Beadstation Scanner and BeadStudio 3. (Fig. 2) . The identical twin sister and parents did not carry this genomic lesion.
Discussion
The present case report presented a Chinese female patient (age, four years and eight months) with a de novo microduplication of 1.6 Mb in 1q21.1. The patient had a normal karyotype and presented with clinical phenotypes comprising several malformations, developmental delay, neuropsychiatric abnormalities, CHD (tetralogy of fallot, patent duct artery and patent foramen ovale), a moderate mental impairment and a decreased ability. To date, no evidence has suggested that children with cyanotic congenital heart disease suffer from decreased mental performance; therefore, the patient's mental impairment was unlikely Values represent the genotype of the tested allele. STR, short tandem repeat.
to be due to oxygen deprivation. However, the identical twin sister of the patient who does not carry the same microduplication was physically and psychologically normal. Using recent SNP array technology, the patient was diagnosed with 1q21.1 duplication syndrome. To the best of our knowledge, the present study was the first to report a patient with 1q21.1 duplication syndrome in mainland China. The chromosome 1q21.1 locus is a complex region with multiple low-copy repeats that make the region susceptible to recurrent deletions and duplications. Large rare copy number variants (CNVs) at this locus as well as microdeletions and microduplications have recently been associated with genomic disorders (OMIM nos. 612474 and 612475), characterized by developmental delay, neuropsychiatric abnormalities, dysmorphic features and a variety of congenital malformations (1,2,13,14) . Two main classes of 1q21.1 CNVs, spanning 20-40 genes, have been described. The more common one (class I; ~1.8 Mb) includes only the distal 1q21.1 region, whereas the longer one (class II, ~2.7 Mb) extends proximally to encompass the thrombocytopenia absent radius (TAR) syndrome region (2) . Congenital heart defect is a major feature of 1q21.1 deletion (3, 5, 6) , and has been occasionally reported in association with 1q21.1 duplication (8, 15) . The prevalence of CHD in a reported series of 1q21.1 deletions was ~30% (3). The anatomic types were heterogeneous, mainly comprising left-sided obstructions (40%), including aortic coarctation, bicuspid aortic valve and subaortic stenosis, but also septal defects (27%) and conotruncal anomalies (20%) (1) . Of note, 1q21.1 duplication was more common in patients with tetralogy of fallot (8) .
In the 1q21.1 locus, the genes GJA5 (7), CHD1 L (8) and PRKAB2 (16) were reported to be closely associated with CHD. The observation that none of them were included in the base sequence of the proband inferred that there may be other genes responsible for the occurrence of CHD. In the present study, the identified chromosome region contained ~30 annotated genes, including HFE2, HYDIN2, RBM8A and CD160. To date, only few studies have associated duplications of these genes with CHD (17, 18) ; the findings of the present study led to the hypothesis that the duplication of these genes caused an increased expression of the coded proteins, which in turn led to CHD. HFE2, which is also in this locus, encodes hemojuvelin (HJV), a protein involved in the activation of hepcidin and iron metabolism. Primarily, HJV is expressed in skeletal muscles, but it is also present at lower levels in the heart and the liver (17) . Furthermore, a soluble form of HJV circulates in plasma. Mutations of this gene are known to be associated with hereditary juvenile hemochromatosis (17, 18) . The gene HYDIN2, a paralogous segment of the primary ciliary dyskinesia-associated gene HYDIN (19) , is involved in the development and formation of organ barriers, and its abnormity also causes congenital heart defects. Deletion/mutation of RBM8A can cause TAR syndrome, characterized by a series of phenotypes including coarctation of the aorta, left ventricular hypertrophy and sub-endocardial fibrosis (20) ; however, it has remained elusive whether duplication of this gene results in congenital heart defects. To confirm this hypothesis, further clinical and molecular biological studies are required.
Given that 1q21.1 duplication may not be well known to clinical cardiologists, the present study will facilitate the clinical recognition of 1q21.1 duplication in China. The results of the high-resolution SNP array in combination with the detailed phenotype analysis provided further evidence for the identification of causative genes for CHD in the 1q21.1 duplication. The present study may aid in the early diagnosis, genetic counseling and effective long-term management of 1q21.1 duplication.
